Study Comparing Two Image Acquisition Modalities for Second-trimester Pregnancy Screening
The second-trimester morphology ultrasound is a key examination in obstetric monitoring that aims to assess fetal growth, identify any structural abnormalities, and inspect anexes such as placenta, umbilical cord, cervix,... Several studies suggest that a significant proportion of fetal malformations can be detected du
| Condition(s) | Artifical Intelligence, Echography Ultrasound |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The second-trimester morphology ultrasound is a key examination in obstetric monitoring that aims to assess fetal growth, identify any structural abnormalities, and inspect anexes such as placenta, umbilical cord, cervix,... Several studies suggest that a significant proportion of fetal malformations can be detected during this time frame if a complete morphological analysis is performed. However, the reliability of the screening depends on the quality of the equipment, the operator's level of expertise, and adherence to protocols that define the necessary scans. In France, since the first reports of the National Technical Committee on Prenatal Screening Ultrasound (2005), particular attention has been paid to standardizing practices. More recently, the French National Conference on Obstet |
| Who can participate | Inclusion Criteria: * Women aged 18 or over, * With a single, viable pregnancy, definitively dated by first-trimester ultrasound, with no known malformations, * Scheduled for a routine second-trimester screening ultrasound, i.e., between 20 weeks + 0 days and 24 weeks + 6 days, * Having given their informed consent, * Affiliated with the social security system or a beneficiary of such a plan. Exclusion Criteria: * Multiple pregnancy, * Known fetal malformation, * Pathological pregnancy, * Cognitive impairment, or a disorder causing difficulty understanding instructions or answering questionnaires, * Patient under legal guardianship, * Patient not covered by health insurance, * Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judici |
| Ages | 18 Years |
| Sex | Female |
| Lead sponsor | Clinique Rive Gauche |
| Locations | Toulouse, France |
| Start date | 2025-12-15 |
| NCT ID | NCT07286591 |
| Official listing | https://clinicaltrials.gov/study/NCT07286591 |